{"id":"https://openalex.org/W2020364588","doi":"https://doi.org/10.2147/tcrm.s30071","title":"Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability","display_name":"Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability","alternate_titles":[],"publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W2020364588","doi":"https://doi.org/10.2147/tcrm.s30071","mag":"2020364588","pmid":"https://pubmed.ncbi.nlm.nih.gov/23818788","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3694507"},"language":"en","primary_location":{"id":"doi:10.2147/tcrm.s30071","doi":"https://doi.org/10.2147/tcrm.s30071","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.s30071","pdf_url":"https://www.dovepress.com/getfile.php?fileID=16177","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2020364588"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=16177","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109095799","display_name":"Chang Yu Pan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802939634","display_name":"Chinese PLA General Hospital","ror":"https://ror.org/04gw3ra78","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2802939634"]},{"id":"https://openalex.org/I4210160531","display_name":"Chinese People's Liberation Army","ror":"https://ror.org/05tf9r976","country_code":"CN","type":"government","lineage":["https://openalex.org/I4210160531"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Chang Yu Pan","raw_affiliation_strings":["Chinese PLA General Hospital, Beijing, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chinese PLA General Hospital, Beijing, People's Republic of China","institution_ids":["https://openalex.org/I2802939634","https://openalex.org/I4210160531"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109495967","display_name":"Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091341","display_name":"Novartis (China)","ror":"https://ror.org/00fxgea47","country_code":"CN","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210091341"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wang","raw_affiliation_strings":["Medical Affairs Department, Beijing Novartis Pharma Co, Ltd, Beijing, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs Department, Beijing Novartis Pharma Co, Ltd, Beijing, People's Republic of China","institution_ids":["https://openalex.org/I4210091341"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5109095799"],"corresponding_institution_ids":["https://openalex.org/I2802939634","https://openalex.org/I4210160531"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":1.0731,"has_fulltext":true,"cited_by_count":28,"citation_normalized_percentile":{"value":0.75849359,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"9","issue":null,"first_page":"247","last_page":"247"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9549999833106995},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8920000195503235},{"id":"https://openalex.org/keywords/metformin-combination-therapy","display_name":"metformin combination therapy","score":0.75},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.8730000257492065},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hypoglycemia-risk","display_name":"hypoglycemia risk","score":0.8429999947547913},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.7369999885559082},{"id":"https://openalex.org/keywords/beta-cell-preservation","display_name":"beta-cell preservation","score":0.8330000042915344},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.6840000152587891},{"id":"https://openalex.org/keywords/patient-acceptability","display_name":"patient acceptability","score":0.7699999809265137},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.8199999928474426}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.9556770324707031},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.940890908241272},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7378661632537842},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5383116006851196},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.44367316365242004},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3898302912712097},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35358184576034546},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2945614457130432},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.18730857968330383}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.2147/tcrm.s30071","doi":"https://doi.org/10.2147/tcrm.s30071","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.s30071","pdf_url":"https://www.dovepress.com/getfile.php?fileID=16177","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2694494","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3694507","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3694507","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3694507/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Clin Risk Manag","raw_type":"Text"},{"id":"pmid:23818788","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23818788","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and clinical risk management","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:4705217882da4bf59895219b54d25600","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4705217882da4bf59895219b54d25600","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutics and Clinical Risk Management, Vol 2013, Iss default, Pp 247-257 (2013)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/13133","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/profile-of-vildagliptin-in-type-2-diabetes-efficacy-safety-and-patient-peer-reviewed-article-TCRM","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.816.123","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.816.123","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/fd/02/tcrm-9-247.PMC3694507.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.2147/tcrm.s30071","doi":"https://doi.org/10.2147/tcrm.s30071","is_oa":true,"landing_page_url":"https://doi.org/10.2147/tcrm.s30071","pdf_url":"https://www.dovepress.com/getfile.php?fileID=16177","source":{"id":"https://openalex.org/S204453222","display_name":"Therapeutics and Clinical Risk Management","issn_l":"1176-6336","issn":["1176-6336","1178-203X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutics and Clinical Risk Management","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2020364588.pdf","grobid_xml":"https://content.openalex.org/works/W2020364588.grobid-xml"},"referenced_works_count":100,"referenced_works":["https://openalex.org/W1518038365","https://openalex.org/W1650518447","https://openalex.org/W1805640194","https://openalex.org/W1932403114","https://openalex.org/W1964285102","https://openalex.org/W1967096313","https://openalex.org/W1967477040","https://openalex.org/W1969389642","https://openalex.org/W1970406523","https://openalex.org/W1970498822","https://openalex.org/W1973383046","https://openalex.org/W1975745949","https://openalex.org/W1977619586","https://openalex.org/W1981473523","https://openalex.org/W1982067008","https://openalex.org/W1984588810","https://openalex.org/W1989976483","https://openalex.org/W2002881577","https://openalex.org/W2003221950","https://openalex.org/W2014972152","https://openalex.org/W2016622896","https://openalex.org/W2019470196","https://openalex.org/W2020638064","https://openalex.org/W2026544876","https://openalex.org/W2027249582","https://openalex.org/W2028317115","https://openalex.org/W2036167841","https://openalex.org/W2043326088","https://openalex.org/W2046503553","https://openalex.org/W2046954222","https://openalex.org/W2047353065","https://openalex.org/W2050046962","https://openalex.org/W2054293703","https://openalex.org/W2054599204","https://openalex.org/W2057632421","https://openalex.org/W2063976195","https://openalex.org/W2065204768","https://openalex.org/W2070657377","https://openalex.org/W2071038866","https://openalex.org/W2074925580","https://openalex.org/W2075746385","https://openalex.org/W2079787842","https://openalex.org/W2079841945","https://openalex.org/W2081276121","https://openalex.org/W2082503109","https://openalex.org/W2089095955","https://openalex.org/W2089154533","https://openalex.org/W2089443047","https://openalex.org/W2092287139","https://openalex.org/W2092883481","https://openalex.org/W2093303670","https://openalex.org/W2095682936","https://openalex.org/W2097704905","https://openalex.org/W2099677425","https://openalex.org/W2100182767","https://openalex.org/W2101293928","https://openalex.org/W2101508556","https://openalex.org/W2101715455","https://openalex.org/W2104079863","https://openalex.org/W2107222124","https://openalex.org/W2107562831","https://openalex.org/W2108842674","https://openalex.org/W2109077746","https://openalex.org/W2111876001","https://openalex.org/W2113936882","https://openalex.org/W2118830784","https://openalex.org/W2119114384","https://openalex.org/W2119702318","https://openalex.org/W2121970519","https://openalex.org/W2123404037","https://openalex.org/W2123946565","https://openalex.org/W2124020657","https://openalex.org/W2124465362","https://openalex.org/W2125468958","https://openalex.org/W2127125241","https://openalex.org/W2129248887","https://openalex.org/W2131498980","https://openalex.org/W2132600168","https://openalex.org/W2137471483","https://openalex.org/W2140047096","https://openalex.org/W2146901298","https://openalex.org/W2154474547","https://openalex.org/W2167621077","https://openalex.org/W2170271198","https://openalex.org/W2172193326","https://openalex.org/W2207468142","https://openalex.org/W2305885852","https://openalex.org/W2337454357","https://openalex.org/W2406523485","https://openalex.org/W2414002317","https://openalex.org/W2510708214","https://openalex.org/W2586645431","https://openalex.org/W2944448728","https://openalex.org/W4234019678","https://openalex.org/W4235139409","https://openalex.org/W4245479565","https://openalex.org/W4251418881","https://openalex.org/W4302130375","https://openalex.org/W6668303560","https://openalex.org/W6674968958"],"related_works":["https://openalex.org/W2374409858","https://openalex.org/W1960382620","https://openalex.org/W1977619586","https://openalex.org/W2020493312","https://openalex.org/W2261093326","https://openalex.org/W1518038365","https://openalex.org/W36699537","https://openalex.org/W1998118816"],"abstract_inverted_index":{"Vildagliptin":[0,113],"is":[1,28,62,114],"a":[2,29,56,118],"selective":[3],"and":[4,22,35,61,74,107,123,142],"potent":[5],"dipeptidyl":[6],"peptidase-4":[7],"inhibitor":[8],"that":[9,49],"improves":[10,71],"glycemic":[11],"control":[12,73],"by":[13],"inhibiting":[14],"the":[15,33,128],"degradation":[16],"of":[17,32,37,59,67,93,121,130],"both":[18],"endogenous":[19],"glucagon-like":[20],"peptide-1":[21],"glucose-dependent":[23],"insulinotropic":[24],"peptide.":[25],"This":[26],"article":[27],"comprehensive":[30],"review":[31],"safety":[34],"efficacy":[36],"vildagliptin":[38,68],"in":[39,81,97,101,104,110],"patients":[40,82],"with":[41,55,85,117],"type":[42],"2":[43],"diabetes.":[44],"Clinical":[45],"evidence":[46],"has":[47,143],"proven":[48],"it":[50,124,148],"effectively":[51],"decreases":[52],"hemoglobin":[53],"A1c":[54],"low":[57,119],"risk":[58,129],"hypoglycemia":[60],"weight":[63],"neutral.":[64],"The":[65],"addition":[66],"to":[69],"metformin":[70,86],"glucose":[72],"significantly":[75],"reduces":[76],"gastrointestinal":[77],"adverse":[78],"events,":[79],"particularly":[80],"inadequately":[83],"controlled":[84],"monotherapy.":[87],"Its":[88],"long-term":[89],"advantages":[90],"include":[91],"preservation":[92],"\u03b2-cell":[94],"function,":[95],"reduction":[96],"total":[98],"cholesterol,":[99],"decrease":[100],"fasting":[102],"lipolysis":[103],"adipose":[105],"tissue,":[106],"triglyceride":[108],"storage":[109],"non-fat":[111],"tissues.":[112],"well":[115,151],"tolerated":[116],"incidence":[120],"AEs,":[122],"does":[125],"not":[126],"increase":[127],"cardiovascular/cerebrovascular":[131],"(CCV)":[132],"events.":[133],"It":[134],"can":[135],"be":[136,150],"taken":[137],"before":[138],"or":[139],"after":[140],"meals,":[141],"little":[144],"drug":[145],"interaction,":[146],"thus":[147],"will":[149],"accepted.":[152]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2020364588","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
